Sarah Côté

823 total citations
26 papers, 496 citations indexed

About

Sarah Côté is a scholar working on Hematology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Sarah Côté has authored 26 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 9 papers in Pathology and Forensic Medicine and 8 papers in Molecular Biology. Recurrent topics in Sarah Côté's work include Multiple Myeloma Research and Treatments (11 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Mechanisms and Therapy (4 papers). Sarah Côté is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Mechanisms and Therapy (4 papers). Sarah Côté collaborates with scholars based in United States, France and Belgium. Sarah Côté's co-authors include Susan Enguídanos, Annette Lam, Jianming He, Jon Ukropec, Kenneth C. Anderson, Mahmoud Hashim, Margarita Kulakova, Bart Heeg, Nikhil C. Munshi and Meletios Α. Dimopoulos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of the American Geriatrics Society.

In The Last Decade

Sarah Côté

25 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Côté United States 8 301 244 195 85 72 26 496
Keqin Qi United States 10 164 0.5× 124 0.5× 180 0.9× 27 0.3× 37 0.5× 33 348
Jennifer Lord‐Bessen United States 9 59 0.2× 104 0.4× 368 1.9× 61 0.7× 29 0.4× 29 574
Ajay Major United States 12 129 0.4× 90 0.4× 158 0.8× 41 0.5× 13 0.2× 60 382
Alain Flinois Switzerland 9 365 1.2× 269 1.1× 254 1.3× 24 0.3× 5 0.1× 25 467
Irmgard Bumeder Germany 9 56 0.2× 98 0.4× 175 0.9× 52 0.6× 10 0.1× 13 357
Sharon Avery Australia 13 272 0.9× 103 0.4× 161 0.8× 95 1.1× 4 0.1× 42 524
Cécile Fortanier France 11 322 1.1× 12 0.0× 109 0.6× 89 1.0× 37 0.5× 19 673
Katharine Batt United States 15 314 1.0× 44 0.2× 87 0.4× 22 0.3× 5 0.1× 49 565
Cindy Murray Canada 10 83 0.3× 31 0.1× 183 0.9× 75 0.9× 6 0.1× 23 400
S J Lee United States 13 357 1.2× 41 0.2× 111 0.6× 188 2.2× 5 0.1× 21 573

Countries citing papers authored by Sarah Côté

Since Specialization
Citations

This map shows the geographic impact of Sarah Côté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Côté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Côté more than expected).

Fields of papers citing papers by Sarah Côté

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Côté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Côté. The network helps show where Sarah Côté may publish in the future.

Co-authorship network of co-authors of Sarah Côté

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Côté. A scholar is included among the top collaborators of Sarah Côté based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Côté. Sarah Côté is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwok, Kelvin H. M., et al.. (2025). Characterization of treatment patterns and outcomes in muscle-invasive bladder cancer patients in Sweden. Scandinavian Journal of Urology. 60. 108–114.
2.
Kastritis, Efstathios, Jessica Vermeulen, Eric M. Ammann, et al.. (2023). Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis. Hematology. 28(1). 2157581–2157581. 6 indexed citations
3.
Dispenzieri, Angela, Jeffrey A. Zonder, James E. Hoffman, et al.. (2022). Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases. Amyloid. 30(2). 161–168. 3 indexed citations
4.
Fonseca, Rafaël, Saad Z. Usmani, Maneesha Mehra, et al.. (2020). Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma. BMC Cancer. 20(1). 1087–1087. 67 indexed citations
5.
6.
Munshi, Nikhil C., Hervé Avet‐Loiseau, Kenneth C. Anderson, et al.. (2020). A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma. Blood Advances. 4(23). 5988–5999. 226 indexed citations
7.
8.
9.
10.
11.
Munshi, Nikhil C., Hervé Avet‐Loiseau, Kenneth C. Anderson, et al.. (2019). Expanded Meta-Analyses Confirms the Association between MRD and Long-Term Survival Outcomes in Multiple Myeloma (MM). Blood. 134(Supplement_1). 4742–4742. 6 indexed citations
12.
Avet‐Loiseau, Hervé, Jianming He, Katharine S. Gries, et al.. (2018). The Relationship between Minimal Residual Disease and Patient Reported Outcomes in Relapsed/Refractory Multiple Myeloma. Blood. 132(Supplement 1). 3273–3273. 1 indexed citations
13.
14.
Kramer, B. Josea, et al.. (2017). Barriers and facilitators to implementation of VA home-based primary care on American Indian reservations: a qualitative multi-case study. Implementation Science. 12(1). 109–109. 19 indexed citations
15.
Xu, Yingxin, et al.. (2017). Front-line treatment of patients with chronic lymphocytic leukemia: a systematic review and network meta-analysis. Journal of Comparative Effectiveness Research. 7(5). 421–441. 6 indexed citations
16.
17.
Côté, Sarah, et al.. (2016). Knowledge About and Perceptions of Advance Care Planning and Communication of Chinese‐American Older Adults. Journal of the American Geriatrics Society. 64(9). 1884–1889. 59 indexed citations
18.
Côté, Sarah, et al.. (2015). Challenges for Assessing The Economic Value of Orphan Drugs - A Literature Review of Current And Alternative Approaches. Value in Health. 18(7). A681–A681. 5 indexed citations
19.
Côté, Sarah, et al.. (2013). The Savvy Caregiver Program: Impact of an Evidence-Based Intervention on the Well-Being of Ethnically Diverse Caregivers. Journal of Gerontological Social Work. 57(6-7). 681–693. 34 indexed citations
20.
Enguídanos, Susan, et al.. (2013). Knowledge and Perceptions of Hospice Care of C hinese Older Adults. Journal of the American Geriatrics Society. 61(6). 993–998. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keqin Qi Breakdown of academic impact, for papers by Jennifer Lord‐Bessen Breakdown of academic impact, for papers by Ajay Major Breakdown of academic impact, for papers by Alain Flinois Breakdown of academic impact, for papers by Irmgard Bumeder Breakdown of academic impact, for papers by Sharon Avery Breakdown of academic impact, for papers by Cécile Fortanier Breakdown of academic impact, for papers by Katharine Batt Breakdown of academic impact, for papers by Cindy Murray Breakdown of academic impact, for papers by S J Lee
Rankless by CCL
2026